Phototherapy system and method
US-2018296854-A1 · Oct 18, 2018 · US
Skin lightener in phototherapy
US2016339263A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2016339263-A1 |
| Application number | US-201615230959-A |
| Country | US |
| Kind code | A1 |
| Filing date | Aug 8, 2016 |
| Priority date | Oct 29, 2011 |
| Publication date | Nov 24, 2016 |
| Grant date | — |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The invention relates, inter alia, to melanin synthesis inhibitors for use in treating skin illnesses, wherein the skin is additionally irradiated with an artificial radiation source. The invention further relates to cosmetic treatments.
First claim
Opening claim text (preview).
1 .- 19 . (canceled) 20 . A method for treatment of skin, comprising treating neonatal jaundice with a combination of at least one skin-lightening compound and irradiation by means of an artificial radiation sources, and wherein the skin of type 21 . The method according to claim 33 , wherein treating the skin with the compound and the light source is carried out in an overlapping manner and/or simultaneously. 22 . The method according to claim 33 , wherein the radiation source emits continuous radiation or pulsed radiation. 23 . The method according to claim 33 , wherein the radiation source is selected from the group consisting of laser, lamp, light-emitting diode (LED); organic light-emitting diode (OLED), polymeric light-emitting diode (PLED) and organic light-emitting electrochemical cell (OLEC, LEC or LEEC). 24 . The method according to claim 33 , wherein the radiation source emits radiation having a wavelength and/or having a wavelength range between 250 and 2000 nm.
Assignees
Inventors
Classifications
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Drugs for dermatological disorders · CPC title
Organic light emitting diodes · CPC title
- A61N5/0621Primary
Hyperbilirubinemia, jaundice treatment · CPC title
Skin treatment other than tanning · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US2016339263A1 cover?
- The invention relates, inter alia, to melanin synthesis inhibitors for use in treating skin illnesses, wherein the skin is additionally irradiated with an artificial radiation source. The invention further relates to cosmetic treatments.
- Who is the assignee on this patent?
- Merck Patent Gmbh
- What technology area does this patent fall under?
- Primary CPC classification A61N5/0621. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Thu Nov 24 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).